Publications from 2002

 

Morino-Koga S., M. Tsuruda, X. Zhao, S. Oshiro, T. Yokomizo, M. Yamane, S. Tanigawa, K. Miike, S. Usuki, K. Yasunaga, R. Nishinakamura, T. Suda, M. Ogawa. Transition of signal requirement in hematopoietic stem cell development from hemogenic endothelial cells. Proc Natl Acad Sci USA, 2024 (in press).

 

Tsuji-Tamura, K. and M. Ogawa. FOXO1 promotes endothelial cell elongation and angiogenesis by up-regulating the phosphorylation of myosin light chain 2. Angiogenesis 26: 523-545, 2023. DOI: 10.1007/s10456-023-09884-7
↓SharedIt link↓
https://rdcu.be/dhEgP

 

Yokomizo, T., T. Ideue, S. Morino-Koga, C. Y. Tham, T. Sato, N. Takeda, Y. Kubota, M. Kurokawa, N. Komatsu, M. Ogawa, K. Araki, M. Osato and T. Suda. Independent origins of fetal liver hematopoietic stem and progenitor cells. Nature 609: 779-784, 2022. DOI: 10.1038/s41586-022-05203-0

 

Tsuruda, M., S. Morino-Koga and M. Ogawa.
Hematopoietic stem cell-independent differentiation of mast cells from mouse intraembryonic VE-cadherin+ cells.
Stem Cells, DOI: 10.1093/stmcls/sxac001
Free-access link below:
https://academic.oup.com/stmcls/advance-article/doi/10.1093/stmcls/sxac001/6516993?guestAccessKey=9570bafc-827d-4986-a02b-1f1b6407d37e

 

Tsuruda, M., S. Morino-Koga and M. Ogawa.
Bone morphogenetic protein 4 differently promotes distinct VE-cadherin+ precursor stages during the definitive hematopoietic development from embryonic stem cell-derived mesodermal cells.
Exp. Hematol. 103: 40-51.e7, 2021. DOI: 10.1016/j.exphem.2021.08.008

 

Tsuji-Tamura, K., S. Morino-Koga, S. Suzuki and M. Ogawa.
The canonical smooth muscle cell marker TAGLN is present in endothelial cells and is involved in angiogenesis.
J. Cell Sci. 134 (15): jcs254920, 2021. DOI: 10.1242/jcs.254920

 

Tsuji-Tamura, K. and M. Ogawa. Morphology regulation in vascular endothelial cells. Inflammation and Regeneration 38:25, 2018. DOI: 10.1186/s41232-018-0083-8.

 

Tsuji-Tamura, K. and M. Ogawa. Dual inhibition of mTORC1 and mTORC2 perturbs cytoskeletal organization and impairs endothelial cell elongation. Biochem. Biophys. Res. Commun. 497: 326-331, 2018.

 

Ahmed, T., K. Tsuji-Tamura and M. Ogawa. CXCR4 signaling negatively modulates the bipotential state of hemogenic endothelial cells derived from embryonic stem cells by attenuating the endothelial potential. Stem Cells 34: 2814-2824, 2016.

 

Nakajima, M., M. Ogawa, Y. Amakura, M. Yoshimura, S. Okuyama and Y. Furukawa. 3,5,6,7,8,3’,4’-Heptamethoxyflavone reduces interleukin-4 production in the spleen cells of mice. Biomed. Res. (Tokyo) 37: 95-99, 2016.

 

Tsuji-Tamura, K. and M. Ogawa. Inhibition of the PI3K/Akt and mTORC1 signaling pathways promotes the elongation of vascular endothelial cells. J. Cell Sci. 129: 1165-1178, 2016.

 

Hirota, S. and M. Ogawa. Activin A in combination with OP9 cells facilitates development of Flk-1+ PDGFRα- and Flk-1+ PDGFRα+ hematopoietic mesodermal cells from murine embryonic stem cells. Biochem. Biophys. Res. Commun. 467: 583-588, 2015.

 

Sakamoto, H., N. Takeda, F. Arai, K. Hosokawa, P. Garcia, T. Suda, J. Frampton and M. Ogawa. Determining c-Myb protein levels can isolate functional hematopoietic stem cell subtypes. Stem Cells 33: 479-490, 2015.

 

Taguchi, A., Y. Kaku, T. Ohmori, S. Sharmin, M. Ogawa, H. Sasaki and R. Nishinakamura. Redefining the in vivo origin of metanephric nephron progenitors enables generation of complex kidney structures from pluripotent stem cells. Cell Stem Cell 14: 53-67, 2014.

http://dx.doi.org/10.1016/j.stem.2013.11.010.

 

Tan, K. S., K. Tamura, M. Lai, A. Veerakumarasivam, Y. Nakanishi, M. Ogawa and D. Sugiyama. Molecular pathways governing development of vascular endothelial cells from ES/iPS cells. Stem Cell Rev. and Rep. 9: 586-598, 2013.

 

Ishida, M., O. El-Mounayri, S. Kattman, P. Zandstra, H. Sakamato, M. Ogawa, G. Keller and M. Husain. Regulated expression and role of c-Myb in the cardiovascular-directed differentiation of mouse embryonic stem cells. Circ. Res. 110: 253-264, 2012.

 

Tsuji-Tamura, K., H. Sakamoto and M. Ogawa. ES cell differentiation as a model to study cell biological regulation of vascular development. ‘Embryonic Stem Cells: The Hormonal Regulation of Pluripotency and Embryogenesis’ ed. Craig Atwood, ISBN 978-953-307-196-1, INTECH, Vienna, Austria, 2011, pp581-606.

 

Kulkeaw, K., Y. Horio, C. Mizuochi, M. Ogawa and D. Sugiyama. Variation in hematopoietic potential of induced pluripotent stem cell lines. Stem Cell Rev. and Rep. 6: 381-389, 2010.

Sakamoto, H., K. Tsuji-Tamura and M. Ogawa. Hematopoiesis from pluripotent stem cell lines (Review). Int. J. Hematol. 91: 384-391, 2010.

 

Kondo, N., M. Ogawa, H. Wada and S-I. Nishikawa. Thrombin induces rapid disassembly of claudin-5 from the tight junction of endothelial cells. Exp. Cell Res. 315: 2879-2887, 2009.

Park, S., H. Sakamoto, K. Tamura, T. Furuyama and M. Ogawa. Foxo1 is essential for in vitro vascular formation from embryonic stem cells. Biochem. Biophys. Res. Commun. 390: 861-866, 2009.

 

Matsukawa, M., H. Sakamoto, M. Kawasuji, T. Furuyama and M. Ogawa. Different roles of Foxo1 and Foxo3 in the control of endothelial cell morphology. Genes Cells 14: 1167-1181, 2009.

 

Huang, X., H. Sakamoto and M. Ogawa. Thrombopoietin controls proliferation of embryonic multipotent hematopoietic progenitors. Genes Cells 14: 851-860, 2009.

 

Hashimoto, K., T. Fujimoto, Y. Shimoda, X. Huang, H. Sakamoto and M. Ogawa. Distinct hemogenic potentials of endothelial cells and CD41⁺ cells in the mouse embryos. Dev. Growth Differ. 49:287-300, 2007.

 

Yokomizo, T., S. Takahashi, N. Mochizuki, T. Kuroha, M. Ema, A. Wakamatsu, R. Shimizu, O. Ohneda, M. Osato, H. Okada, T. Komori, M. Ogawa, S-I. Nishikawa, Y. Ito and M. Yamamoto. Characterization of GATA-1 + hemangioblastic cells in the mouse embryo. EMBO J. 26: 184-196, 2007.

 

Guo, R., H. Sakamoto, S. Sugiura and M. Ogawa. Endothelial cell motility is compatible with junctional integrity. J. Cell. Physiol. 211: 327-335, 2007.

 

Sugiyama, D. , M. Ogawa, K. Nakao, N. Osumi, S. Nishikawa, S-I. Nishikawa, K-I. Arai, T. Nakahata and K. Tsuji. B cell potential can be obtained from pre-circulatory yolk sac, but with low frequency. Dev. Biol. 301: 53-61, 2007.

 

Dai, G., H. Sakamoto, Y. Shimoda, T. Fujimoto, S-I. Nishikawa and M. Ogawa. Over-expression of c-Myb increases the frequency of hemogenic precursors in the endothelial cell population. Genes Cells 11: 859-870, 2006.

 

Sakamoto, H., G. Dai, K. Tsujino, K. Hashimoto, X. Huang, T. Fujimoto, M. Mucenski, J. Frampton and M. Ogawa. Proper levels of c-Myb are discretely defined at distinct steps of hematopoietic cell development. Blood 108: 896-903, 2006.

 

Kogata, N., Y. Arai, J.T. Pearson, K. Hashimoto, K. Hidaka, T. Koyama, S. Somekawa, Y. Nakaoka, M. Ogawa, R.H. Adams, M. Okada and N. Mochizuki. Cardiac ischemia activates vascular endothelial cadherin promoter in both pre-existing vascular cells and bone marrow cells involved in neovascularization. Circ. Res. 98: 897-904, 2006.

 

Nakajima, M., M. Ogawa, Y. Shimoda, S. Hiraoka, M. Iida, H. Koseki, T. Shirasawa and K. Furukawa. Presenilin-1 controls the growth and differentiation of endothelial progenitor cells through its b-catenin-binding region. Cell Biol. Int. 30: 239-243, 2006.

 

Hisatsune, H., K. Matsumura, M. Ogawa, A. Uemura, N. Kondo, J. K. Yamashita, H. Katsuta, S. Nishikawa, T. Chiba and S-I. Nishikawa. High level of endothelial cell-specific gene expression by a combination of the 5′ flanking region and the 5′ half of the first intron of the VE-cadherin gene. Blood 105: 4657-4663, 2005.

 

Furuyama, T., K. Kitayama, Y. Shimoda, M. Ogawa, K. Sone, K. Yoshida-Araki, H. Hisatsune, S-I. Nishikawa, K. Nakayama, K. Nakayama, K. Ikeda, N. Motoyama and N. Mori. Abnormal angiogenesis in Foxo1 (Fkhr)-deficient mice. J. Biol. Chem. 279: 34741-34749, 2004.

 

Sakamoto, H., X. Zhang, S. Suenobu, K. Ohbo, M. Ogawa and T. Suda. Cell adhesion to ephrinb2 is induced by EphB4 independently of its kinase activity. Biochem. Biophys. Res. Commun. 321: 681-687, 2004.

 

Sugiyama, D., M. Ogawa, I. Hirose, T. Jaffredo, K-I. Arai and K. Tsuji. Erythropoiesis from acetyl LDL incorporating endothelial cells at the pre-liver stage. Blood 101: 4733-4738, 2003.

 

Schroeder, T., S. Fraser, M. Ogawa, S. Nishikawa, C. Oka, G. Bornkamm, S-I. Nishikawa, T. Honjo and U. Just. Recombination signal sequence-binding protein Jk alters mesodermal cell fate decisions by suppressing cardiomyogenesis. Proc. Natl. Acad. Sci. USA 100: 4018-4023, 2003.

 

Fraser, S., M. Ogawa, T. Yokomizo, Y. Ito, S. Nishikawa and S-I. Nishikawa. Putative intermediate precursor between hematogenic endothelial cells and blood cells in the developing embryo. Develop. Growth Differ. 45: 63-75, 2003.

 

Yurugi-Kobayashi, T., H. Itoh, J. Yamashita, K. Yamahara, H. Hirai, T. Kobayashi, M. Ogawa, S. Nishikawa, S-I. Nishikawa and K. Nakao. Effective contribution of transplanted vascular progenitor cells derived from embryonic stem cells to adult neovascularization in proper differentiation stages. Blood 101: 2675-2678, 2003.

 

Hidaka, K., J-K. Lee, H. S. Kim, C. H. Ihm, A. Iio, M. Ogawa, S-I. Nishikawa, I. Kodama and T. Morisaki. Chamber-specific differentiation of Nkx2.5-positive cardiac precursor cells from murine embryonic stem cells. FASEB J. 17: 740-742, 2003.

 

Hirashima, M, M. Ogawa, S. Nishikawa, K. Matsumura, K. Kawasaki, M. Shibuya and S-I. Nishikawa. A chemically defined culture of VEGFR2+ cells derived from embryonic stem cells revealed the role of VEGFR1 in tuning the threshold for VEGF in developing endothelial cells. Blood 101: 2261-2267, 2003.

 

Matsumura, K., M. Hirashima, M. Ogawa, H. Kubo, H. Hisatsune, N. Kondo, S. Nishikawa, T. Chiba and S-I. Nishikawa. Modulation of VEGFR-2-mediated endothelial-cell activity by VEGF-C/VEGFR-3. Blood 101: 1367-1374, 2003.

 

Hirai, H., M. Ogawa, N. Suzuki, M. Yamamoto, G. Breier, O. Mazda, J. Imanishi and S-I. Nishikawa. Hemogenic and non-hemogenic endothelium can be distinguished by the activity of fetal liver kinase (Flk)-1 promoter/enhancer during mouse embryogenesis. Blood 101: 886-893, 2003.

 

Endoh, M., M. Ogawa, S. Orkin and S-I. Nishikawa. SCL/tal-1 dependent process determines a competence to select the definitive hematopoietic lineage prior to endothelial differentiation. EMBO J. 21: 6700-6708, 2002.

 

Uemura, A., M. Ogawa, M. Hirashima, T. Fujiwara, S. Koyama, H. Takagi, Y. Honda, S. J. Wiegand, G. D. Yancopoulos and S-I. Nishikawa. Recombinant angiopoietin-1 restores higher order architecture on growing blood vessels in absence of mural cells. J. Clin. Invest. 110: 1619-1628, 2002.

 

Fraser, S., M. Ogawa, R. Yu, S. Nishikawa, M. Yoder and S-I. Nishikawa. Definitive hematopoietic commitment within the embryonic vascular endothelial-cadherin+ population. Exp. Hematol. 30: 1070-1078, 2002.

 

Miyashita, H., T. Yamazaki, T. Akada, O. Niizeki, M. Ogawa, S-I. Nishikawa and Y. Sato. A mouse orthologue of puromycin insensitive leucyl-specific aminopeptidase (PILSAP) is expressed in endothelial cell and plays an important role in angiogenesis. Blood 99: 3241-3249, 2002.

 

Fraser, S., M. Ogawa, S. Nishikawa and S-I. Nishikawa. Embryonic stem cell differentiation as a model to study hematopoietic and endothelial cell development. Methods in Molecular Biology 185: 71-81, 2002.